As EY Global Life Sciences Tax Leader, Mitch works with pharmaceutical, biotechnology and medical device clients.
His experience includes transaction integration, large pharmaceutical mergers, joint venture planning, leasing, debt restructuring, financial instruments and amortization of intangible assets.
Mitchell has extensive knowledge in corporate and partnership taxation, tax processes and systems, accounting methods and research tax credits.
He received a BS in Accounting from Syracuse University and a JD from the State University of New York at Buffalo.
How Mitchell is building a better working world
“In more than 30 years serving clients in many industries, including the last 15 in life sciences, I’ve seen organizations change and transform themselves as they adapt to the changing environment around them. These changes have never been as rapid or as fluid as they are today. This rate of change, driven by technology, is creating many exciting opportunities to help deliver value to clients.”